iiinova — where your digital self keeps evolving

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 29/09/2026

A new approach to anatomy teaching at the DBM: Felix Margenfeld and colleagues developed an ultrasound-guided dissection course, connecting real-time ultrasound with anatomical structures to strengthen students’ 3D understanding of the human body. 🔗 edoc.unibas.ch/entities/pub... @unibas.ch

001 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 24/09/2026

The fourteenth issue of our DBM Newsletter is here! Happy reading!👇🏼👇🏼👇🏼 DBM Newsletter Issue 14: issuu.com/departementb... @biomedizin.unibas.ch #Newsletter #Research #Science #Biomedicine

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 22/09/2026

Congratulations to Gregor Hutter on his appointment as Clinical Professor of Neurosurgery at @unibas.ch. At @biomedizin.unibas.ch, @hutterlab.bsky.social studies how immune cells can be harnessed against glioblastoma and develops new therapies. Congratulations, Gregor! 🎉

110 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 15/09/2026

🎉Congratulations to David Bargiela on his @snsf.ch Ambizione Grant! His new project investigates how glioblastoma cells survive treatment and adapt their metabolism following immune attack – with the aim of identifying vulnerabilities that could improve responses to immunotherapies! What a success!

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 09/09/2026

The 2026 DBM Summer Symposium took place on September 9. 🧬 We started with a keynote by Prof. @stephenquake.bsky.social, followed by four sessions showcasing research by our scientists. The day concluded with the DBM Paper Prize & Best Presentation Award. 🏆 #DBMSymposium2026 #TeamDBM #Science

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 08/09/2026

A new way to turn the tumor microenvironment against cancer: Researchers from Cambridge and Basel developed small molecules that make macrophages engulf cancer cells while reducing PD-L1-mediated immune suppression. Published in Cancer Research. 👇Publication link below. #CancerResearch

Green-stained macrophages engulf red-labeled cancer cells after treatment with PSEs. The red signal inside the macrophages shows that they have taken up cancer cells. (Image: Valerio Sabatino, University of Basel)

100 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 03/09/2026

The ISREC Foundation awarded two TANDEM grants to support collaborative cancer research involving DBM researchers. 🔬 The projects explore immune evasion in leukemia and T cell dysfunction in solid tumors. Congratulations to all the researchers involved! 👉 biomedizin.unibas.ch/en/newsdetai...

biomedizin.unibas.ch

Two TANDEM Grants by the ISREC Foundation strengthen translational cancer research at the DBM

The ISREC Foundation has awarded TANDEM Grants to two research projects involving scientists and clinicians from the Department of Biomedicine (DBM). These projects address significant challenges in c...

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 02/09/2026

Mini-tumors help uncover new treatment options for liver cancer. Researchers led by Markus Heim and Sandro Nuciforo from @biomedizin.unibas.ch screened >1,600 compounds in patient-derived organoids and identified promising drug combinations that work across diverse tumors. 👇

110 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 27/08/2026

🏆 Congratulations to Prof. Judith Zaugg and Prof. Heinz Läubli, DBM research group leaders and recipients of the 2026 Dora Seif Prize for Cancer Research! A wonderful recognition of their outstanding contributions to cancer research. 👏 #CancerResearch #DoraSeifPrize #DBM @unibas.ch

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 11/08/2026

A patient's search for answers led to the discovery of a new type of immune disorder Researchers identified a mosaic mutation affecting only a specific subgroup of immune cells, opening new possibilities for precision diagnosis and targeted treatment for patients with unexplained immune disorders.

111 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 04/08/2026

New in @jamaneurology.com: Jens Kuhle from @biomedizin.unibas.ch, @unibas.ch and @dkf.unibas.ch together with other colleagues shows that the blood biomarker GFAP is associated with progression independent of relapses in multiple sclerosis and may complement NfL. Congratulations to the team! 👏👇

Data from thousands of blood samples allowed the researchers to compare different biological processes involved in multiple sclerosis. (Photo: Kathleen Herrgott, RC2NB)

110 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 30/07/2026

New study led by Aikaterini Lampada from the Taylor lab @biomedizin.unibas.ch finds the septum — not just the hippocampus — makes new neurons in adult mice, triggered by both stress and the antidepressant fluoxetine. Serotonin seems to be the switch. 🧠 👉 doi.org/10.1126/sciadv.aed3625 @science.org

doi.org

Mice produce interneurons in the septum as a response to aversive experiences and antidepressant treatment

Aversive experiences and antidepressant treatment stimulate neuron production in the adult septum.

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 28/07/2026

Dr. @mariuslange.bsky.social has been appointed Tenure-Track Assistant Professor of Systems Developmental Medicine. He combines computational biology & single-cell genomics to study how human tissues & organs develop, thereby advancing our understanding of early childhood development. 👇

110 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 14/07/2026

🧠 Great news from the Molecular Neuroscience Lab! Professor Andreas Papassotiropoulos has been elected to the German National Academy of Sciences Leopoldina — one of the most prestigious scientific honors in the German-speaking world. Congratulations, Andreas! 🎉 biomedizin.unibas.ch/en/newsdetai...

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 30/06/2026

Another ERC success for @biomedizin.unibas.ch: Judith Zaugg has been awarded an #ERCPoC Grant for HemaTrax, a project improving the prediction of blood toxicity in cancer therapy and drug development. It could support safer treatments and speed up the development of new therapies. 👍 @erc.europa.eu

040 4

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 29/05/2026

🔬 Two new studies from the Pinschewer Lab at the DBM shed new light on antiviral immunity — from Lassa fever vaccination to B cell “attrition” in chronic infection. Congratulations to the team! 👏 Nature Communications: www.nature.com/articles/s41... PNAS: www.pnas.org/doi/10.1073/...

Fluorescence microscopy of mouse spleen tissue comparing chronic infection with a virus to which adoptively transferred B cells bind with high affinity (top) versus infection with a virus bound at low affinity (bottom). Green marks the transferred B cells, red the germinal centers where B cells mature, white the surrounding B cell zone. (Dimitrova et al., PNAS 2026, Fig. 2H–I. Reproduced under CC BY licence.)

121 2

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 27/05/2026

The thirteenth issue of our DBM Newsletter is here! Happy reading!👇🏼👇🏼👇🏼 DBM Newsletter Issue 13: issuu.com/departementb... @biomedizin.unibas.ch #Newsletter #Research #Science #Biomedicine

issuu.com

DBM Newsletter No. 13

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 19/05/2026

Congratulations to Heinz Läubli on his appointment as Clinical Professor of Cellular Therapies at the @unibas.ch. Heinz has helped establish Basel as a leader in translational cancer immunotherapy and innovative cell therapies, including as CAR-T and TIL cells. biomedizin.unibas.ch/en/newsdetai...

biomedizin.unibas.ch

New professorship for Cellular Therapies (Läubli Lab)

The University Council of the University of Basel has appointed Professor Heinz Läubli as Clinical Professor of Cellular Therapies at the Faculty of Medicine.

030 3

Reposted by Department of Biomedicine🔬🧪

Graduate Center University of Basel @grace-unibasel.bsky.social · 11/05/2026

Pitch Lab @unibas.ch, Wed May 13, 5:30–8:30 PM at the Biozentrum. Bring an early-stage idea or come as a collaborator. All faculties, all levels welcome. Food + drinks provided. One idea wins a prize + uniBIA support. Submit your idea: buff.ly/MQVphwt Come as collaborator: buff.ly/flpg40x

021 2

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 28/04/2026

Congratulations on this great achievement, Karen!👏

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 28/04/2026

Lifelong viral infections acquired at birth are not immunologically silent. A @biomedizin.unibas.ch & @unibas.ch study shows that Tfh-driven antibody responses partly control virus, but remain limited. Boosting CD4 T cell help may offer new therapeutic avenues. www.sciencedirect.com/science/arti...

sciencedirect.com

Perinatal infection elicits clonally restricted T follicular helper cell responses that drive antibody-mediated viral control

Perinatal infection often results in viral persistence, as observed for hepatitis B virus in humans. Commonly held concepts suggest that persistence i…

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 17/04/2026

MISEV2023 sets key guidelines for EV research. With contributions from Edveena Hanser, Diego Kyburz, & an international consortium, the paper is now one of the top ten most-cited papers in JEV (Wiley, 2024). Congratulations to everyone involved. isevjournals.onlinelibrary.wiley.com/doi/10.1002/...

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 10/04/2026

📺 TV tip The ZDF documentary “plan b: A fresh start for the knee” features research from the @biomedizin.unibas.ch , @unibas.ch, on cartilage regeneration using patients’ own cells. 📅 10 April, 19:40 (ARTE) and 12 April, 15:30 (ZDF) Also available online. Link in comments. @dkf.unibas.ch

110 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 01/04/2026

Welcome on board @Frauke von Versen. We are happy to have you with us, and we wish you a great start! #Welcome2026 #welcometotheteam #welcomeonboard #TeamDBM @biomedizin.unibas.ch n.unibas.ch DBM News: 👉 biomedizin.unibas.ch/en/newsdetai...

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 31/03/2026

Aβ and tau disrupt memory circuits in Alzheimer’s disease. New work from the @marcaurelbusche.bsky.social Lab at @biomedizin.unibas.ch .ch and @uclhresearch.bsky.social bsky.social links this to synaptic NMDA receptor hypofunction and shows recovery when both pathologies are reduced. 🔗See comments.

100 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 19/03/2026

Construction has begun on the facade of our new DBM building. It features 2039 electrochromic glass panes that darken automatically in sunlight, regulating daylight while maintaining clear views outside. 🔗Read more: biomedizin.unibas.ch/en/communica... @biomedizin.unibas.ch @unibas.ch

biomedizin.unibas.ch

New DBM Building – A Facade Reflecting Innovation

With the arrival of spring, the new building of the Department of Biomedicine (DBM) at the University of Basel is starting to take shape: the installation of its glass facade is now underway. The faca...

050 5

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 10/03/2026

🔬 Science moves forward through collaboration! Researchers from @biomedizin.unibas.ch and the Department of Pharmaceutical Sciences (DPhW) came together for the DBM–DPhW Joint Meeting 2026 — a day of inspiring talks, exchange, and new connections across disciplines. 👏 #DBM #DPhW #LifeSciences

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 03/03/2026

Today, we’ve officially launched the Xenium platform at @biomedizin.unibas.ch in collaboration with @bsse.ethz.ch. 🚀 A major step forward for spatial transcriptomics in Basel! 👉 biomedizin.unibas.ch/en/communica...

062 6

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 13/02/2026

On Wednesday, we hosted the symposium, “Sex & Gender Differences in Medicine & Research,” with Athena’s Journey. Sex & gender influence disease risk, symptoms & outcomes - yet they are underrepresented in research. Integrating them isn’t optional. It’s essential. #SexandGender #ClosingTheGap #IDWGS

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 11/02/2026

This year, we are celebrating the International Day of Women and Girls in Science with a behind-the-scenes video, "A Day in the Life of a PhD Student." The video highlights the importance of women's participation in STEM. 🌟 Watch & share! Video Link. vimeo.com/1163620393?f... #IDWGS #WomenInScience

vimeo.com

A Day In the Life of a PhD-Student: International Day of Women and Girls in Science 2026

This is "A Day In the Life of a PhD-Student: International Day of Women and Girls in Science 2026" by Department of Biomedicine on Vimeo, the home for…

020 2

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 30/01/2026

The 12th issue of our DBM Newsletter is here! We hope you enjoy reading it.👇🏼👇🏼👇🏼 DBM Newsletter Issue 12: issuu.com/departementb... @biomedizin.unibas.ch #Newsletter #Research #Science #Biomedicine

issuu.com

DBM Newsletter No. 12

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 23/01/2026

DBM Research Day 2026 has wrapped up! 🎉 There were great talks and lively discussions, as well as an excellent poster session showcasing emerging research across DBM. Thanks to everyone involved! See you in 2027! #DBMResearchDay #Science #TeamDBM @biomedizin.unibas.ch

041 4

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 20/01/2026

How does aggressive AML originate? A new study shows that thrombopoietin can prime EVI1+ stem cells, making them more vulnerable to KMT2A fusion–driven leukemia, published in @natcomms.nature.com from the Schwaller lab @biomedizin.unibas.ch. 👉 www.nature.com/articles/s41... #AML @unibas.ch

Wright-Giemsa stained cytospin preparations of murine long-term hematopoietic stem cells. (Image: Hugues-Étienne Châtel-Soulet, University of Basel).

010 1

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 14/01/2026

How can a common virus contribute to a rare disease? A new @cp-immunity.bsky.social study from @biomedizin.unibas.ch links EBV to early MS-like lesion formation by showing how B cells can act at the very start of the disease process. 🔗 doi.org/10.1016/j.ce... @unibas.ch #EBV #MultipleSclerosis

Confocal micrograph of the mouse brain. The myelin sheaths that wrap the the axons of neurons are shown in red. The blue cells are infected with a virus. Such infections cause immune cells to enter the brain. If these immune cells attack the myelin, autoimmune disease can result. Image by Hyein Kim (University of Basel).

186 8

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 12/01/2026

Two back-to-back BJH papers from the XPAG-ITP trial! 🎉 ETB+dexamethasone showed longer response & less rescue therapy vs dex alone in ITP. Immune profiling reveals baseline TCR clonality predicts durable remission. 🔗 onlinelibrary.wiley.com/doi/10.1111/... #ITP #Hematology #TranslationalResearch

Artistic rendering of platelets and immune cells highlighting immune dynamics in immune thrombocytopenia. Generated with AI.

000 0

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 09/01/2026

How can we tell whether an antibiotic eradicates an infection? Researchers from the @biomedizin.unibas.ch, at the @unibas.ch, present an antimicrobial single-cell microscopy-based method that measures antibiotic lethality in individual bacteria. 🔗 doi.org/10.1038/s415... @natmicrobiol.nature.com

Some bacterial pathogens play dead to dodge antibiotics. A new test watches them closely—and helps choose drugs that finish the job. (Symbolic image: Adobe Stock)

097 9

Department of Biomedicine🔬🧪 @biomedizin.unibas.ch · 23/12/2025

As we wrap up 2025, we’re wishing you peaceful days filled with rest, joy, and good company. 🌟 Thank you for being part of our community this year. Happy Holidays and all the very best for 2026 — from all of us at the @ biomedizin.unibas.ch ! #HappyHolidays #NewYear2026 #Biomedicine #UniBasel

000 0